home · filing · 0001104659-23-024920
8-K
filed February 24, 2023, 6:59 PM ET
ticker DRIO
CIK 0001533998
leadership
confidence high
sentiment neutral
materiality 0.30
DarioHealth appoints Jon Kaplan to board of directors
DarioHealth Corp.
Jon Kaplan appointed to board effective February 22, 2023; board expanded by one seat.
Kaplan is Managing Director and Senior Partner at Boston Consulting Group (BCG).
Previously served on advisory boards of Livongo, Transcarent, Circulation, and Picwell.
Will receive same compensation as other non-executive directors.
Kaplan brings healthcare strategy experience; CEO cites critical timing for strategic relationships.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Appointed
Jon Kaplan
Director
Effective 2023-02-22
Filed February 24, 2023, 6:59 PM ET
expanded the Board by one seat and appointed Jon Kaplan as a member of the Board, effective immediately.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 1.0
Jon Kaplan was appointed as Director at DarioHealth Corp..
Action appointed
Role Director
Exact text from the filing
expanded the Board by one seat and appointed Jon Kaplan as a member of the Board, effective immediately.
View on SEC.gov
Source: SEC EDGAR
accession 0001104659-23-024920
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.